Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Moodys
Citi
QuintilesIMS
Chinese Patent Office
Dow
Covington
Harvard Business School
Farmers Insurance

Generated: May 23, 2018

DrugPatentWatch Database Preview

Potassium aminosalicylate - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for potassium aminosalicylate and what is the scope of potassium aminosalicylate patent protection?

Potassium aminosalicylate
is the generic ingredient in two branded drugs marketed by Glenwood and Hexcel, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two hundred and thirty-five drug master file entries for potassium aminosalicylate.
Summary for potassium aminosalicylate
Synonyms for potassium aminosalicylate
133-09-5
65-49-6 (Parent)
7N21461LKD
AC1Q1U2B
AC1Q1U2P
AK251010
AKOS024323786
Aminosalicylate Potassium
Aminosalicylate potassium [USP]
API0009000
Benzoic acid, 4-amino-2-hydroxy-, monopotassium salt
Benzoic acid, 4-amino-2-hydroxy-, potassium salt (1:1)
Benzoic acid,4-amino-2-hydroxy-, potassium salt (1:1)
C7H6NO3.K
CHEMBL1200584
CTK4B8346
D0S2BT
DTXSID3059634
EINECS 205-090-7
LS-172852
MCULE-8313817847
Monopotassium 4-aminosalicylate
OR047775
OR214050
p-Aminosalicylate acid potassium salt
p-Aminosalicylic Acid Monopotassium Salt
PASKALIUM
potassium 4-amino-2-hydroxybenzoate
Potassium 4-aminosalicylate
potassium paraaminosalicylate
SCHEMBL1477512
UNII-7N21461LKD

US Patents and Regulatory Information for potassium aminosalicylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenwood PASKALIUM potassium aminosalicylate TABLET;ORAL 009395-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hexcel POTASSIUM AMINOSALICYLATE potassium aminosalicylate POWDER;ORAL 080098-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glenwood PASKALIUM potassium aminosalicylate CAPSULE;ORAL 009395-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Deloitte
Accenture
Dow
Express Scripts
Healthtrust
Baxter
Citi
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.